[en] Morganella morganii produces an inducible, chromosomally encoded AmpC beta-lactamase. We describe in this study three new variants of AmpC within this species with apparent pIs of 6.6 (M19 from M. morganii strain PP19), 7.4 (M29 from M. morganii strain PP29), and 7.8 (M37 from M. morganii strain PP37). After gene sequencing, deduced amino acid sequences displayed one to six substitutions when compared to the available Morganella AmpC sequences. An AmpR-encoding gene was also found upstream of ampC, including the LysR regulators' helix-turn-helix DNA-binding domain and the putative T-N-11-A-protected region in the ampR-ampC intercistronic sequence. All three AmpC variants were purified from in vitro-generated derepressed mutants and showed overall similar kinetic parameters. None of the observed amino acid changes, occurring at the surface of the protein, appear to have a major influence in their catalytic properties. Morganella AmpCs exhibit the highest catalytic efficiencies (k(cat)/K-m) on classical penicillins, cefoxitin, narrow-spectrum cephalosporins, and cefotaxime. Cefotaxime was more effectively hydrolyzed than other oxyimino-cephalosporins, whereas cefepime was 3 log-fold less efficiently hydrolyzed than other cephalosporins such as cephalothin. Several differences with other AmpC beta-lactamases were found. Ampicillin was more efficiently hydrolyzed than benzylpenicillin. High k(cat)/K-m values were observed for oxacillin and piperacillin, which are usually poor substrates for AmpC. A fairly efficient hydrolysis of imipenem was detected as well. Aztreonam, carbenicillin, and tazobactam were effective transient inactivators of these variants.
Disciplines :
Pharmacy, pharmacology & toxicology Microbiology
Author, co-author :
Power, Pablo ; Université de Liège - ULiège > Macromolécules biologiques
Galleni, Moreno ; Université de Liège - ULiège > Département des sciences de la vie > Macromolécules biologiques
Ayala, J. A.
Gutkind, G.
Language :
English
Title :
Biochemical and molecular characterization of three new variants of AmpC beta-lactamases from Morganella morganii
Publication date :
March 2006
Journal title :
Antimicrobial Agents and Chemotherapy
ISSN :
0066-4804
eISSN :
1098-6596
Publisher :
Amer Soc Microbiology, Washington, United States - Washington
Akova, M., Y. Yang, and D. M. Livermore. 1990. Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed class I β-lactamases. J. Antimicrob. Chemother. 25:199-208.
Alvarez, M., J. H. Tran, N. Chow, and G. A. Jacoby. 2004. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob. Agents Chemother. 48:533-537.
Barnaud, G., G. Arlet, C. Danglot, and A. Philippon. 1997. Cloning and sequencing of the gene encoding the AmpC β-lactamase of Morganella morganii. FEMS Microbiol. Lett. 148:15-20.
Barnaud, G., G. Arlet, C. Verdet, O. Gaillot, P. H. Lagrange, and A. Philippon. 1998. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42:2352-2358.
Bartowsky, E., and S. Normark. 1993. Interactions of wild-type and mutant AmpR of Citrobacter freundii with target DNA. Mol. Microbiol. 10:555-565.
Bekal, S., J. van Beeumen, B. Samyn, D. Garmyn, S. Henini, C. Diviès, and H. Prévost. 1998. Purification of Leuconostoc mesenteroides citrate lyase and cloning and characterization of the citCDEFG gene cluster. J. Bacteriol. 180:647-654.
Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
De Meester, F., B. Joris, G. Reckinger, C. Bellefroid-Bourguignon, J. M. Frère, and S. G. Waley. 1987. Automated analysis of enzyme inactivation phenomena. Application to β-lactamases and DD-peptidases. Biochem. Pharmacol. 36:2393-2403.
Eliopoulos, G. M. 1988. Induction of β-lactamases. J. Antimicrob. Chemother. 22:37-44.
Everett, M., T. Walsh, G. Guay, and P. Bennett. 1995. GevA, a LysR-type transcriptional regulator protein, activates expression of the cloned Citrobacter freundii ampC β-lactamase gene in Escherichia coli: cross-talk between DNA-binding proteins. Microbiology 141:419-430.
Fortineau, N., L. Poirel, and P. Nordmann. 2001. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:207-210.
Gaillot, O., C. Clement, M. Simonet, and A. Philippon. 1997. Novel transferable β-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J. Antimicrob. Chemother. 39:85-87.
Galleni, M., G. Amicosante, and J.-M. Frère. 1988. A survey of the kinetic parameters of class C β-lactamases. Cephalosporins and other β-lactam compounds. Biochem. J. 255:123-129.
Galleni, M., and J.-M. Frère. 1988. A survey of the kinetic parameters of class C β-lactamases. Penicillins. Biochem. J. 255:119-122.
Gerhardt, P., R. G. E. Murray, W. A. Wood, and N. R. Krieg. 1994. Methods for general and molecular bacteriology. ASM Press, Washington, D.C.
Ghuysen, J. M. 1991. Serine β-lactamases and penicillin-binding- proteins. Annu. Rev. Microbiol. 45:37-67.
Hames, B. D. 1981. An introduction to polyacrylamide gel electrophoresis. In B. D. Hames and D. Rickwood (ed.), Gel electrophoresis of proteins: a practical approach. IRL Press, Oxford, United Kingdom.
Jacobs, C., J.-M. Frère, and S. Normark. 1997. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in Gram-negative bacteria. Cell 88:823-832.
Liebana, E., M. Batchelor, F. A. Clifton-Hadley, R. H. Davies, K. L. Hopkins, and E. J. Threlfall. 2004. First report of Salmonella isolates with the DHA-1 AmpC β-lactamase in the United Kingdom. Antimicrob. Agents Chemother. 48:4492.
Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
Matagne, A., A. Dubus, M. Galleni, and J.-M. Frère. 1999. The β-lactamase cycle: a tale of selective pressure and bacterial ingenuity. Nat. Prod. Rep. 16:1-19.
Matagne, A., J. Lamotte-Brasseur, G. Dive, J. R. Knox, and J. M. Frère. 1993. Interactions between active-site serine β-lactamases and compounds bearing a methoxy side chain on the α-face of the β-lactam ring: kinetic and molecular modelling studies. Biochem. J. 293:607-611.
Matagne, A., J. Lamotte-Brasseur, and J.-M. Frère. 1998. Catalytic properties of class A β-lactamases: efficiency and diversity. Biochem. J. 330:581-598.
Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
Muñoz, V., and L. Serrano. 1997. Development of the multiple sequence approximation within the AGADIR model of alpha-helix formation: comparison with Zimm-Bragg and Lifson-Roig formalisms. Biopolymers 41:495-509.
Naas, T., D. M. Livermore, and P. Nordmann. 1995. Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing β-lactamase Sme-1, and comparison of this regulator with other β-lactamase regulators. Antimicrob. Agents Chemother. 39:629-637.
Naas, T., and P. Nordmann. 1994. Analysis of a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc. Natl. Acad. Sci. USA 91:7693-7697.
Nakano, Y., Y. Yoshida, Y. Yamashita, and T. Koga. 1995. Construction of a series of pACYC-derived plasmid vectors. Gene 162:157-158.
National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed., vol. 20. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
Nielsen, H., J. Engelbrecht, S. Brunak, and G. von Heijne. 1997. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10:1-6.
Poirel, L., M. Guibert, D. Girlich, T. Naas, and P. Nordmann. 1999. Cloning, sequence analysis, expression, and distribution of ampC·ampR from Morganella morganii. Antimicrob Agents Chemother. 43:769-776.
Power, P., M. Radice, C. Barberis, C. de Mier, M. Mollerach, M. Maltagliatti, C. Vay, A. Famiglietti, and G. Gutkind. 1999. Cefotaxime- hydrolysing β-lactamases in Morganella morganii. Eur. J. Clin. Microbiol. Infect. Dis. 18:743-747.
Sambrook, J., E. F. Fristch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
Sanger, I., S. Nicklen, and A. Coulson. 1977. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
Schwede, T., J. Kopp, N. Guex, and M. C. Peitsch. 2003. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31:3381-3385.
Toda, M., M. Inoue, and S. Mitsuhashi. 1981. Properties of cephalosporinase from Proteus morganii. J. Antibiot. 34:1469-1475.
Yan, J.-J., W.-C. Ko, Y.-C. Jung, C.-L. Chuang, and J.-J. Wu. 2002. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J. Clin. Microbiol. 40:3121-3126.
Yang, Y., and D. M. Livermore. 1988. Chromosomal β-lactamase expression and resistance to β-lactam antibiotics in Proteus vulgaris and Morganella morganii. Antimicrob. Agents Chemother. 32:1385-1391.
Yong, D., Y. Lim, W. Song, Y. S. Choi, D.-Y. Park, H. Lee, J. H. Yum, K. Lee, J. M. Kim, and Y. Chong. 2005. Plasmid-mediated, inducible AmpC β-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis. Diagn. Microbiol. Infect. Dis. 53:65-70.